6281 - 6290 of 8620 Results
Title
Year
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 9
-
RESTRICTEDTitle: Cropland associated with risk of Parkinson's disease in the northern Great PlainsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107288End Page: 107288Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107288Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107288Citation Count: 0
-
OPENTitle: PDKit: A data science toolkit for the digital assessment of Parkinson’s DiseaseJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 3Start Page: e1008833End Page: e1008833Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1008833Best OA location URL: https://doi.org/10.1371/journal.pcbi.1008833Citation Count: 5
- Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels2017OPENTitle: Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levelsJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-017-0978-zBest OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-017-0978-zCitation Count: 67
- Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study2018OPENTitle: Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association studyJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-018-1023-6Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-018-1023-6Citation Count: 17
- Loss of glutamic acid decarboxylase (Gad67) in Gpr88-expressing neurons induces learning and social behavior deficits in mice2014RESTRICTEDTitle: Loss of glutamic acid decarboxylase (Gad67) in Gpr88-expressing neurons induces learning and social behavior deficits in miceJournal Name: NeurosciencePublisher: Elsevier BVVol: 275Issue #:Start Page: 238End Page: 247Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.06.020Citation Count: 37
- K2S2O8-mediated coupling of 6-amino-7-aminomethyl-thiazolino-pyridones with aldehydes to construct amyloid affecting pyrimidine-fused thiazolino-2-pyridones2021OPENTitle: K2S2O8-mediated coupling of 6-amino-7-aminomethyl-thiazolino-pyridones with aldehydes to construct amyloid affecting pyrimidine-fused thiazolino-2-pyridonesJournal Name: Organic & Biomolecular ChemistryPublisher: Royal Society of Chemistry (RSC)Vol: 19Issue #: 44Start Page: 9758End Page: 9772Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1ob01580jBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2021/ob/d1ob01580jCitation Count: 1
- Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling2017OPENTitle: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signalingJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0153-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0153-4Citation Count: 51
- Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study2019RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 34
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease2018OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 143